SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population

Abroad (travel likely)RecruitingPHASE1

Conditions

Uncontrolled Hypertension

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China
Contact: Study coordinator (Chongyuan Xu, Ph.D) · nflcyljd@smu.edu.cn · 13926186470
Contact: Principal Investigator (Chongyuan Xu, Ph.D)

Study leads

Chongyuan Xu, Ph.D
Principal Investigator
Nanfang Hospital, Southern Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension

Uncontrolled Hypertension

Abroad (travel likely)RecruitingPHASE2

Beijing, China

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

Hypertension · Uncontrolled Hypertension

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Tempe, United States

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

High Risk Cardiovascular Disease · Hypertension · High Cardiovascular Risk

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Birmingham, United States

Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

Hypertension · Vascular Diseases · Cardiovascular Diseases

Abroad (travel likely)Recruiting

Melbourne, Australia · Perth, Australia